Jefferies Group’s Amedisys AMED Stock Holding History

Jefferies Group’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-150,700	Closed	-$2.59M	–	1895
2013 Q3	$2.59M	Sell	150,700 -49,300	-25%	-$731K	0.03%	514
2013 Q2	$2.32M	Buy	+200,000	New	+$2.29M	0.02%	458

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Jefferies Group's AMED Position: Q1 2021 in Review

Jefferies Group sold out of Amedisys (AMED) in Q1 2021, closing a stake of 7,000 shares — an estimated $2.05M sold.

Jefferies Group first reported a position in AMED in Q2 2013 and held it in 3 quarters. The position peaked at $2.05M in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

Jefferies Group reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
Jefferies Group sold 7,000 Amedisys shares in Q1 2021, an estimated $2.05M.
Jefferies Group first reported a position in Amedisys in Q2 2013 and held it in 3 quarters.
Jefferies Group's Amedisys position peaked at $2.05M in Q4 2020.
388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Jefferies Group's 13F filing for Q1 2021, filed 14 May 2021.